Carillon Tower Advisers’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-485,595
| Closed | -$31.6M | – | 501 |
|
2020
Q3 | $31.6M | Buy |
485,595
+20,878
| +4% | +$1.36M | 0.42% | 63 |
|
2020
Q2 | $34M | Sell |
464,717
-57,100
| -11% | -$4.17M | 0.26% | 122 |
|
2020
Q1 | $15.5M | Hold |
521,817
| – | – | 0.15% | 208 |
|
2019
Q4 | $28.4M | Sell |
521,817
-168,600
| -24% | -$9.18M | 0.19% | 189 |
|
2019
Q3 | $28.8M | Hold |
690,417
| – | – | 0.2% | 171 |
|
2019
Q2 | $30.2M | Hold |
690,417
| – | – | 0.21% | 169 |
|
2019
Q1 | $35.5M | Hold |
690,417
| – | – | 0.25% | 150 |
|
2018
Q4 | $25.5M | Hold |
690,417
| – | – | 0.22% | 180 |
|
2018
Q3 | $25.9M | Hold |
690,417
| – | – | 0.19% | 195 |
|
2018
Q2 | $27.3M | Hold |
690,417
| – | – | 0.21% | 163 |
|
2018
Q1 | $16.9M | Hold |
690,417
| – | – | 0.13% | 224 |
|
2017
Q4 | $18.6K | Buy |
+690,417
| New | +$18.6K | 0.2% | 182 |
|